Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

CONTRIBUTING WRITER

Deepak Balak, MD, MSc
Erasmus MC, Department of Dermatology
Utrecht, Netherlands

Dr. Balak works as a dermatologist at the Department of Dermatology and Allergology of the University Medical Center Utrecht in Utrecht, the Netherlands, where he combines patient care with teaching responsibilities and research. His clinical interests are centered on the impact and management of inflammatory and autoimmune diseases. His scientific interests include translational medicine, clinical drug development, and evaluation in the field of chronic immune-mediated inflammatory skin diseases, such as psoriasis. As a 2019 Fellow, he will study with Dr. Alice Gottlieb at the Mount Sinai Hospital in New York, New York and attend the European Academy of Dermatology and Venereology Congress.

Last Updated: Nov 20, 2019

Latest news

October 23, 2020
Commentary provided on this international moderate-severe psoriasis case series, where biologics use was associated with lower risk of COVID-19-related hospitalization than non-biologic systemic therapies, however further investigation is warranted due to potential selection bias and unmeasured confounding.
October 15, 2020
PsoProtect, the global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data so that it now includes the first 200 cases.
October 06, 2020
IPC Founding President Alan Menter and IPC Councilor Ulrich Mrowietz discuss the new guidance on psoriasis care from the National Psoriasis Foundation COVID-19 Task Force.
October 05, 2020
Christopher EM Griffiths and Mahira Hamdy El Sayed use science to counter misinformation about psoriasis. These two dermatologists discuss natural treatments for psoriasis, how lifestyle can affect the immune system, and the rosy future of psoriasis treatment.
  More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK